Seres Therapeutics, Inc. (Nasdaq:MCRB) announced on 10/22/18 the appointment of Kevin Horgan, M.D., as Executive Vice President and Chief Medical Officer. Dr. Horgan will lead Seres’ clinical development, clinical operations, regulatory affairs, and medical affairs functions. Dr. Horgan will succeed Seres’ outgoing Chief Medical Officer, Michele Trucksis, Ph.D., M.D., who will continue to provide consulting services to the Company.
“I am delighted to welcome Dr. Kevin Horgan as our Chief Medical Officer, reporting directly to me. Kevin is an accomplished drug developer with extensive experience successfully leading numerous mid- and late-stage clinical programs to approval. Seres’ R&D efforts are increasingly focused on early and later stage immunological indications, and Kevin’s deep clinical background in these areas makes him very well suited to lead our clinical development studies,” said Roger J. Pomerantz, M.D., President, CEO and Chairman of Seres. “I would also like to thank Shelley for her contributions to Seres, which included initiating and completing several of the first microbiome therapeutic clinical studies ever conducted. We appreciate her continued consulting through the transition.
Over a three-decade academic and industry career, Dr. Horgan has contributed to the development and approval of multiple therapeutics across immunology and oncology indications. Most recently, Dr. Horgan was Vice President of Clinical Development at AstraZeneca where he led the development of combination immune-oncology programs. Dr. Horgan earlier co-founded Tucana Health, a microbiome diagnostics company. Previously, Dr. Horgan held Chief Medical Officer roles at Soligenix and Coronado. Prior to those roles, he was Vice President of Clinical Immunology at Centocor during the development and approval of Remicade, Stelara and Simponi, approved for inflammatory bowel disease indications. Dr. Horgan began his industry career at Merck, following positions in academic medicine at the University of California, Los Angeles and immunologic training at the National Cancer Institute. Dr. Horgan earned his medical degree from University College Cork in Ireland. He did his medical residency on the Osler Service, at The Johns Hopkins Hospital.